The taxation of innovation in the United States has historically functioned as a delicate equilibrium between the necessity of federal revenue and the strategic imperative to incentivize industrial and technological advancement. Central to this legal and economic architecture is the treatment of research and experimental expenditures, a domain that was fundamentally democratized by the Supreme Court’s landmark decision in Snow v. Commissioner, 416 U.S. 500 (1974). By interpreting the statutory language of Section 174 with a breadth that recognized the unique lifecycle of burgeoning enterprises, the Court established a precedent that has served as the bedrock for the modern startup ecosystem. However, the landscape of research and development (R&D) taxation has recently undergone its most volatile period in seventy years, shifting from the traditional immediate expensing model to a mandatory amortization regime under the Tax Cuts and Jobs Act (TCJA) of 2017, and finally to a bifurcated restoration of expensing under the One Big Beautiful Bill Act (OBBBA) of 2025. This study provides an exhaustive examination of the Snow v. Commissioner case, the subsequent development of the “realistic prospect” test, the disruption caused by the TCJA, and the future of R&D tax credit applications in an environment defined by the emergence of Section 174A.

The Historical and Legislative Antecedents of Section 174

To appreciate the transformative impact of the Snow decision, one must first analyze the pre-1954 tax environment. Prior to the enactment of the Internal Revenue Code of 1954, no specific statutory provision existed to govern the deductibility of research and experimental costs. Taxpayers were largely dependent on the general “ordinary and necessary” business expense standards of the predecessor to Section 162. This lack of specificity created a profound systemic bias in favor of large, established corporations. Major industrial firms with ongoing research departments were typically able to absorb R&D costs as current operating expenses, as their activities were inextricably linked to an existing, revenue-generating trade or business. Conversely, small businesses, independent inventors, and newly formed partnerships were frequently forced to capitalize these expenditures, as the IRS often categorized them as pre-opening costs or capital investments in an asset with an indeterminate useful life.

Congress recognized that this disparity stifled the very innovation required for national economic and military strength. In 1954, Section 174 was introduced to eliminate the “confusion and uncertainty” that had historically plagued small innovators. Representative Reed of New York, then Chairman of the House Committee on Ways and Means, explicitly articulated that the goal was to equalize the tax benefits between established companies and those small businesses without dedicated research departments. The resulting statute allowed taxpayers to elect to either currently deduct research and experimental expenditures or to capitalize and amortize them over a period of not less than sixty months. The operative phrase in the new Section 174 was that expenditures must be incurred “in connection with” the taxpayer’s trade or business.

Despite this clear legislative intent, the Commissioner of Internal Revenue and the lower courts continued to apply a restrictive interpretation for the first two decades of the statute’s existence. They often attempted to import the more rigorous “carrying on a trade or business” standard from Section 162 into the Section 174 analysis. This required a taxpayer to be actively engaged in the sale of goods or services at the time the expenditures were incurred—a standard that proved nearly impossible for R&D-intensive startups to meet during their pre-revenue developmental phases. This fundamental tension between the broad language of Section 174 and the restrictive judicial application of the time culminated in the Snow v. Commissioner litigation.

Analysis of Snow v. Commissioner: Facts and Procedural History

The case originated from the 1966 tax return of Edwin A. Snow, a limited partner in the Burns Investment Company. Snow had contributed $10,000 for a four-percent interest in the partnership, which was formed specifically to develop a “special purpose incinerator” for both consumer and industrial markets. The general partner, a professional inventor named Trott, had previously formed two other partnerships, Echo and Courier, for the development of a telephone answering device and an electronic tape recorder, respectively. By 1966, Trott had developed several prototypes of the incinerator, but patent counsel advised that the device had not yet been sufficiently “reduced to practice” for successful commercialization.

During the 1966 tax year, the Burns Investment Company focused entirely on research and development. It reported no sales, and its activities were limited to shopwork performed by an outside engineering firm under Trott’s supervision, with Trott himself dedicating approximately one-third of his professional time to the project. The partnership reported a net operating loss consisting entirely of R&D expenditures, and Snow sought to deduct his pro-rata share of this loss on his individual income tax return under Section 174.

The Commissioner of Internal Revenue disallowed the deduction, and the United States Tax Court sustained this disallowance in a 1972 decision. The Tax Court’s reasoning was anchored in the belief that the partnership was not yet engaged in a trade or business because it had no product ready for sale and had not held itself out to others as being engaged in the selling of goods or services. The Court of Appeals for the Sixth Circuit affirmed this decision in 1973, reinforcing the view that Section 174 expenditures must be incurred by a taxpayer who is already an “operating” business. This created an apparent conflict with the Fourth Circuit’s decision in Cleveland v. Commissioner, prompting the Supreme Court to grant certiorari.

The Supreme Court’s Rationale and the Textual Distinction

The Supreme Court’s decision reversing the Sixth Circuit was predicated on a meticulous textual analysis of the Internal Revenue Code, and was joined by all participating Justices except Justice Stewart, who took no part in the case. Justice Douglas, writing for the Court, emphasized that the words “trade or business” appear in numerous sections of the 1954 Code, but their meaning is not uniform. The Court drew a sharp contrast between Section 162(a), which allows for the deduction of ordinary and necessary expenses paid or incurred in “carrying on” any trade or business, and Section 174(a)(1), which covers expenditures paid or incurred “in connection with” his trade or business.

The Court observed that the “carrying on” language of Section 162 had been narrowly construed to require that a taxpayer already be actively engaged in business operations. However, by utilizing the phrase “in connection with,” Congress intended to establish a much broader and more inclusive standard for Section 174. Justice Douglas argued that to apply the Section 162 standard to Section 174 would “defeat the congressional purpose” of equalizing tax benefits between established, ongoing companies and those “upcoming and about to reach the market”.

The Court further supported its decision by referencing the legislative history of the 1954 Code, noting that the provision was specifically designed as an economic incentive for small and growing businesses. By allowing these firms to deduct R&D costs during the pre-revenue phase, the tax code could effectively subsidize the risky and often lengthy period of product development. This interpretation transformed Section 174 into a vital lifeline for the venture capital industry, as it permitted the pass-through of R&D losses to investors, thereby reducing the net cost of innovation.

Post-Snow Refinements and the Realistic Prospect Test

While Snow v. Commissioner established that a taxpayer does not need to be currently selling products to qualify for a Section 174 deduction, it did not eliminate the requirement that the research be conducted as part of a bona fide business endeavor as opposed to a mere investment activity. In the decades following Snow, the federal courts developed a more sophisticated framework to differentiate legitimate entrepreneurial ventures from passive tax shelters. This framework is commonly referred to as the “realistic prospect” test.

The realistic prospect test mandates that for a pre-revenue enterprise to claim Section 174 deductions, it must demonstrate that there is a realistic prospect that the technology being developed will eventually be exploited in the taxpayer’s own trade or business. The analysis is comprehensive and focuses on both the subjective intent of the taxpayer and the objective ability of the taxpayer to commercialize the research results.

Critical Criteria for the Realistic Prospect Test

The development of the realistic prospect test was primarily driven by appellate cases involving limited partnerships that funded research but granted third parties the exclusive rights to exploit the resulting technology. The courts have identified several dispositive factors:

• Management and Control: In Harris v. Commissioner, the court emphasized that the entity incurring the research expenses must actually manage and control the use or marketing of the research results. A mere contractual right to receive royalties is generally viewed as an investment activity rather than a trade or business.
• Infrastructure and Expertise: In Levin v. Commissioner and Kantor v. Commissioner, the courts found that the taxpayers lacked the necessary infrastructure, specialized knowledge, or technical personnel to commercialize the intellectual property on their own. If a partnership is structured such that it is contractually or practically incapable of manufacturing or marketing the product, it fails the realistic prospect test.
• Exclusive Licensing Options: A common pitfall for many R&D partnerships was granting the research firm a nominal-cost option to acquire the exclusive rights to the technology. In Kantor, the court noted that such an arrangement effectively precluded the partnership from ever engaging in its own business related to that technology.

The cumulative effect of these cases was to refine the Snow precedent into a functional standard that supports legitimate startup ventures while protecting the integrity of the tax system. For modern R&D tax credit applications, the realistic prospect test remains a vital consideration, especially for pharmaceutical and technology companies that often operate for many years before bringing a product to market.

The Section 174 Test as a Gatekeeper for Section 41 Credits

The importance of the Snow decision and Section 174 is amplified by its direct relationship to the Section 41 Credit for Increasing Research Activities. The research credit is one of the most complex provisions in the Internal Revenue Code, but its entry point is remarkably simple: an expenditure must first qualify under Section 174 to even be considered for the credit. This is known as the “Section 174 Test”.

The Section 41 definition of “qualified research” begins with the requirement that the expenditures “may be treated as specified research or experimental expenditures under section 174”. Because Snow v. Commissioner defines the “trade or business” requirement for Section 174, it effectively defines it for the research credit as well. Without the broad “in connection with” interpretation provided by the Supreme Court, pre-revenue startups would be legally ineligible for the R&D tax credit, regardless of how much technological uncertainty they were attempting to resolve.

Integrating Snow into the Four-Part Test

For an activity to qualify for the Section 41 credit, it must satisfy a rigorous four-part test:

1. The Section 174 Test: The expenditures must be treatable as Section 174 R&E costs, which means they must relate to activities intended to discover information that would eliminate technical uncertainty concerning the development or improvement of a product. Under Snow, this requirement is met even by “upcoming” businesses.
2. Technological in Nature Test: The research must rely on the principles of the physical or biological sciences, engineering, or computer science.
3. Business Component Test: The research must be intended to develop or improve a new or improved business component, which includes products, processes, software, techniques, or formulas.
4. Process of Experimentation Test: Substantially all (at least 80%) of the research activities must constitute a process of experimentation, involving the systematic evaluation of alternatives to achieve a result where the capability, method, or design is uncertain at the outset.

The Section 174 test is the foundational pillar of this framework. If a startup fails to meet the “in connection with” trade or business standard as interpreted in the wake of Snow, the remaining three tests are moot. Consequently, the Snow decision is the legal mechanism that allows the entire U.S. innovation economy to leverage the Section 41 credit before they have realized their first dollar of revenue.

The Disruption of the Tax Cuts and Jobs Act of 2017

For decades, the immediate expensing of R&D costs under Section 174 was a constant in American tax policy. This era came to an end with the Tax Cuts and Jobs Act (TCJA) of 2017. To fund the significant reduction in the corporate tax rate, Congress implemented several revenue-raising offsets, one of which was the mandatory capitalization and amortization of Section 174 expenditures.

Effective for tax years beginning after December 31, 2021, the TCJA eliminated the option to immediately deduct research and experimental costs. Instead, taxpayers were required to capitalize these “Specified Research or Experimental” (SRE) expenditures and amortize them over five years for domestic research or fifteen years for research conducted outside the United States.

Technical Mechanics of TCJA Amortization

The TCJA’s amortization regime introduced several complexities that significantly impacted the financial statements of R&D-intensive companies:

• Mid-Year Convention: Regardless of when the expenditures were incurred during the year, taxpayers were required to use a mid-year convention, effectively allowing only a 10% deduction (half of the first-year 20% amortization) in the year the costs were paid or incurred.
• Software Development Inclusion: The TCJA specifically added a new provision, Section 174(c)(3), which mandated that all costs incurred in connection with the development of software be treated as SRE expenditures. This effectively forced the entire software industry into the amortization regime, regardless of whether their activities previously qualified as “research and development” under traditional definitions.
• Non-Recovery on Abandonment: In a move that departed from traditional cost recovery principles, the TCJA added Section 174(d), which prohibits the immediate recovery of the remaining unamortized basis if the underlying property is disposed of, retired, or abandoned. If a research project fails and is terminated, the company must continue the amortization schedule for the full five or fifteen years.

This shift from 100% deductibility to 10% deductibility in the first year created significant cash flow pressure for many startups and small manufacturers. Because taxable income is calculated before these R&D deductions, companies were often required to pay taxes on income that did not reflect their actual cash position—cash that had already been spent on engineers, lab supplies, and research contracts. The 2022 to 2024 period represents a significant departure from the pro-innovation philosophy articulated in Snow v. Commissioner.

Administrative Guidance and the Persistence of the Snow Standard

In the wake of the TCJA, the IRS and the Treasury Department faced the task of issuing guidance on how to identify SRE expenditures in this new era of capitalization. It is noteworthy that despite the statutory move away from immediate expensing, the administrative guidance explicitly preserved the broad Snow v. Commissioner standard for determining the scope of Section 174.

IRS Notice 2023-63 and the “In Connection With” Affirmation

Released in September 2023, Notice 2023-63 provided the first comprehensive interim guidance on the SRE expenditure regime. The notice reaffirmed that an expenditure is an SRE expenditure if it is paid or incurred “in connection with” the taxpayer’s trade or business. Crucially, the notice cited Snow v. Commissioner to confirm that this standard is broader than the “carrying on” requirement of Section 162.

This affirmation had dual consequences. On one hand, it ensured that startups and emerging companies were still “in the game” for potential R&D benefits once they reached profitability. On the other hand, it also meant that these same pre-revenue startups were legally required to capitalize and amortize their R&D costs during the 2022–2024 period, often leading to a reduction in their net operating losses (NOLs) and creating potential future tax liabilities.

The “Risks and Rights” Standard for Contract Research

The guidance also sought to address the treatment of research performed under contract, a common scenario for many technology and life sciences firms. Borrowing heavily from the judicial concepts of “active involvement” and the “realistic prospect” test, the IRS introduced a “risks and rights” test for research providers.

A research provider (the party performing the work for a client) must treat their costs as SRE expenditures if they either bear the financial risk of the research’s failure or retain a right to use or exploit the results of the research. If a provider performs research under a “work-for-hire” arrangement where all IP and risk transfer to the client, the provider may generally deduct their costs as ordinary business expenses under Section 162, while the client (the “research recipient”) must treat the contract payments as SRE expenditures subject to amortization. This distinction creates significant tax planning opportunities and pitfalls for engineering firms and federal contractors.

The One Big Beautiful Bill Act (OBBBA) and Section 174A

The industry-wide outcry following the 2022 implementation of Section 174 amortization finally reached a legislative crescendo in 2025 with the passage of the One Big Beautiful Bill Act (OBBBA), signed on July 4, 2025. This landmark legislation fundamentally restored the status quo for domestic research while maintaining the TCJA’s restrictive stance on foreign innovation.

The Emergence of Section 174A and Immediate Expensing

The OBBBA introduced a new code section, Section 174A, which governs domestic research a